- Capital Cube•2 months ago
Click here to see latest analysisAlexza Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Alexza Pharmaceuticals, Inc. – DURECT Corporation, Aradigm Corporation, BioDelivery Sciences International, Inc., Titan Pharmaceuticals, Inc., Paratek Pharmaceuticals Inc, Vanda Pharmaceuticals Inc., Nektar Therapeutics, Teva Pharmaceutical Industries Limited Sponsored […] (Read more...) The post Alexza Pharmaceuticals, Inc. :ALXA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 appeared first on CapitalCube.
- Zacks•3 months ago
On Tuesday, shares of pharmaceutical company Alexza Pharmaceuticals (ALXA) are soaring, up over 66% in afternoon trading after the company announced it has entered into a definitive agreement to be acquired by Spain-based Ferrer Pharma Inc.
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||0|
As of 3:53 PM EDT. Market closed.